GlassScriptPhysician profile
Geri Schmitt
NPI 1982896239
$2,199.03
in general payments reported to CMS, 2019-2025
24 companies · $418 in 2025
The $418 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $76.38 · 2022: $262 · 2023: $544 · 2024: $394 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $420.22 | 2019-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $222.06 | 2019-2024 | Veozah |
| Abbvie INC. | $178.61 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $151.42 | 2022-2025 | Paragard T 380a, Mara Console |
| Meditrina | $118.76 | 2023-2024 | |
| Exeltis, USA INC. | $108.41 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $107.40 | 2023-2024 | Gemtesa, Myfembree |
| Vertical Pharmaceuticals, LLC | $92.43 | 2019 | |
| Mayne Pharma Commercial LLC | $80.62 | 2022-2025 | |
| Shield Therapeutics INC | $79.11 | 2023-2025 | Accrufer |
| Myovant Sciences INC. | $74.80 | 2022 | |
| Organon LLC | $60.24 | 2023-2025 | Nexplanon |
| Pfizer INC. | $59.65 | 2020-2023 | |
| Allergan, INC. | $54.58 | 2019 | |
| Ethicon US, LLC | $52.30 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $49.91 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $47.72 | 2023 | Thinprep 2000 Processor |
| Urovant Sciences INC | $43.31 | 2022 | |
| Boston Scientific Corporation | $40.23 | 2025 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $40.20 | 2020-2025 | |
| Axonics, INC. | $35.24 | 2023 | Bulkamid |
| Merck Sharp & Dohme LLC | $34.84 | 2019 | |
| Therapeuticsmd, INC. | $28.75 | 2019 | |
| Davol INC. | $18.22 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geri Schmitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.